November - 2023

News

How Israeli technology saved 78-year-old Leah from skin cancer

Alpha-emitting Radiation Therapy Could Create a Paradigm Shift in Cancer Treatment

Alpha DaRT treatment proves a success in first-in-human trial

Israel's alpha radiation treatment shows tumor shrinkage in 100% of cases

Alpha Tau Announces the Publication of Exceptional Clinical Data from Alpha DaRT, its Novel Alpha Ra

Israeli MedTech Start-up, Alpha Tau Medical, Raises $29 Million in Private Financing to Cure Cancer

Alpha Tau’s High-Precision Cancer Radiotherapy Receives Radioactive-Safety Approval in the United St

First Alpha Tau Medical Summit Gathers Over 200 Oncologists and Physicians From all Around the World

Nov 29, 2023

Alpha Tau to Participate in Sidoti Small-Cap Conference

JERUSALEM, November 29, 2023 -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the...

Nov 28, 2023

Alpha DaRT Advanced Pancreatic Cancer Trial : Highly Promising Interim Results

- Interim data read-out of the first five treated patients demonstrated successful delivery in all five cases, as well as no...

Nov 20, 2023

ATM submits to Japanese PMDA for Pre-Market Approval of Alpha DaRT for Recurrent Head & Neck Cancer

Jerusalem, November 20, 2023 -- Alpha Tau Medical Ltd. ("Alpha Tau") (NASDAQ: DRTS, DRTSW), the developer of the innovative...

Nov 19, 2023

Alpha Tau Medical Announces Third Quarter 2023 Financial Results and Provides Corporate Update

- Treated the first patient with advanced inoperable pancreatic cancer at Hadassah Medical Center in Israel in September, alongside...

Nov 1, 2023

Alpha Tau to Participate in November Investor Conferences

JERUSALEM, November 1, 2023 -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the...